Jpmorgan Chase & Co »

Merrimack Pharma shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $91k 6.8k 13.41
2023-09-30 $84k 6.8k 12.33
2023-06-30 $103k 8.3k 12.30
2022-12-31 $4.0k 354 11.30
2020-09-30 $0 7 0.00
2020-06-30 $0 681 0.00
2020-03-31 $24k 11k 2.17
2019-12-31 $33k 10k 3.20
2019-09-30 $0 100 0.00
2019-06-30 $1.0k 100 10.00
2019-03-31 $232k 33k 6.94
2018-12-31 $217k 56k 3.87
2018-09-30 $294k 55k 5.33
2018-06-30 $0 100 0.00
2018-03-31 $26k 3.0k 8.43
2017-12-31 $31k 3.2k 9.74